Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;13(4):PCC.11l01152.
doi: 10.4088/pcc.11l01152.

Sertraline and low-dose doxepin treatment in severe agitated-anxious depression with significant gastrointestinal complaints:two case reports

Lisa Maclean  1 , Brian K Ahmedani
Affiliations

Sertraline and low-dose doxepin treatment in severe agitated-anxious depression with significant gastrointestinal complaints:two case reports

Lisa Maclean et al. Prim Care Companion CNS Disord. 2011.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Olgiati P., Serretti A., Colombo C. Retrospective analysis of psychomotor agitation, hypomanic symptoms, and suicidal ideation in unipolar depression. Depress Anxiety. 2006;23(7):389–397. - PubMed
    1. Hamilton M. Distinguishing between anxiety and depressive disorders. In: Last S.C.A., Hersen M., editors. Handbook of Anxiety Disorders. New York, NY: Pergamon Press; 1988. pp. 143–145.
    1. North C.S., Hong B.A., Alpers D.H. Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment. World J Gastroenterol. 2007;13(14):2020–2027. - PMC - PubMed
    1. Addolorato G., Mirijello A., D'Angelo C., et al. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract. 2008;62(7):1063–1069. - PubMed
    1. Lydiard R.B., Falsetti S.A.Experience with anxiety and depression treatment studies: implications for designing irritable bowel syndrome clinical trials Am J Med 19991075A65S–73S - PubMed